Home › Funds › HighVista Strategies LLC › LBRX

HighVista Strategies LLC position in LBRX

LB PHARMACEUTICALS INC · Health Care

HighVista Strategies LLC reported holding 173,804 shares of LBRX (LB PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$6.7M, representing 1.75% of its reported portfolio and ranking #11 among its reported holdings. HighVista Strategies LLC has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)173.80K sh
Reported value held$6.67M
Portfolio Weight1.75%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HighVista Strategies LLC's LBRX position evolved

HighVista Strategies LLC first disclosed a stake in LBRX in Q4 2025 at 140,107 shares (US$3.1M). The position peaked in Q2 2026 at 211,511 shares, worth US$6.9M. Across 4 filings, HighVista Strategies LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 173,804 shares valued at US$6.7M — a reduction of -37,707 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 140.11K $3.12M New
Q1 2026 173.59K $4.28M Add
Q2 2026 211.51K $6.86M Add
Q3 2026 173.80K $6.67M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LBRX and 13F data

LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 106 other funds we track also report a position in LBRX — the largest reported positions include Deep Track Capital, LP (US$108.8M), RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Trails Edge Capital Partners, LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LBRX

All LBRX fund holders →

FAQ

How long has HighVista Strategies LLC held LBRX?

HighVista Strategies LLC has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is HighVista Strategies LLC's current position in LBRX?

As of Q3 2026, HighVista Strategies LLC holds 173.80K shares of LBRX (LB PHARMACEUTICALS INC), valued at $6.67M, representing 1.75% of its reported portfolio and ranking #11.

Has HighVista Strategies LLC been buying or selling LBRX?

In the latest 13F filing (Q3 2026), HighVista Strategies LLC reduced its position in LBRX. The position peaked in Q2 2026 at 211.51K shares.

Which other funds hold LBRX?

Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Trails Edge Capital Partners, LP, among 106 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.